Literature DB >> 10933043

Allogeneic astrocytoma in immune competent dogs.

M E Berens1, A Giese, J R Shapiro, S W Coons.   

Abstract

We have induced in canines long-term immune tolerance to an allogeneic cell line derived from a spontaneous canine astrocytoma. Allogeneic astrocytoma cells were implanted endoscopically into the subcutaneous space of fetal dogs before the onset of immune competency (< 40th gestational day). At adulthood, dogs rendered tolerant successfully serve as recipients of intracranial transplants of their growing allogeneic, subcutaneous tumor. Transplanted dogs subsequently develop a solid brain tumor with histological features similar to the original astrocytoma. This model may allow rapid development and evaluation of new therapies for brain tumors, as well as afford tumor biology studies that are untenable in smaller, immune incompetent, or inbred animals harboring less representative tumors.

Entities:  

Mesh:

Year:  1999        PMID: 10933043      PMCID: PMC1508127          DOI: 10.1038/sj.neo.7900020

Source DB:  PubMed          Journal:  Neoplasia        ISSN: 1476-5586            Impact factor:   5.715


  53 in total

1.  P53 mutations in mammary tumor cell lines and corresponding tumor tissues in the dog.

Authors:  I S Van Leeuwen; E Hellmèn; C J Cornelisse; B Van den Burgh; G R Rutteman
Journal:  Anticancer Res       Date:  1996 Nov-Dec       Impact factor: 2.480

2.  Implantable biodegradable polymers for IUdR radiosensitization of experimental human malignant glioma.

Authors:  J A Williams; L E Dillehay; K Tabassi; E Sipos; C Fahlman; H Brem
Journal:  J Neurooncol       Date:  1997-05       Impact factor: 4.130

3.  Increasing volume of distribution to the brain with interstitial infusion: dose, rather than convection, might be the most important factor.

Authors:  R A Kroll; M A Pagel; L L Muldoon; S Roman-Goldstein; E A Neuwelt
Journal:  Neurosurgery       Date:  1996-04       Impact factor: 4.654

Review 4.  A review: CNS effects and normal tissue tolerance in dogs.

Authors:  P R Gavin; S L Kraft; R Huiskamp; J A Coderre
Journal:  J Neurooncol       Date:  1997-05       Impact factor: 4.130

5.  Retrospective review of 50 canine intracranial tumors evaluated by magnetic resonance imaging.

Authors:  S L Kraft; P R Gavin; C DeHaan; M Moore; L R Wendling; C W Leathers
Journal:  J Vet Intern Med       Date:  1997 Jul-Aug       Impact factor: 3.333

6.  Naturally occurring cancer in pet dogs: important models for developing improved cancer therapy for humans.

Authors:  D W Knapp; D J Waters
Journal:  Mol Med Today       Date:  1997-01

Review 7.  Induced tolerance and chimaerism in human fetuses using coelocentesis: a medical opportunity to avert genetic disease?

Authors:  R G Edwards; E Jauniaux; R M Binns; M Layton; D Jurkovic; T A Grillo; S Campbell
Journal:  Hum Reprod Update       Date:  1995-07       Impact factor: 15.610

8.  Induction of antitumor immunity by intracerebrally implanted rat C6 glioma cells genetically engineered to secrete cytokines.

Authors:  S H Tseng; L H Hwang; S M Lin
Journal:  J Immunother       Date:  1997-09       Impact factor: 4.456

Review 9.  Correlation of animal brain tumor models with human neuro-oncology.

Authors:  L J Rubinstein
Journal:  Natl Cancer Inst Monogr       Date:  1977-12

10.  Animal models of brain tumors.

Authors:  D Crafts; C B Wilson
Journal:  Natl Cancer Inst Monogr       Date:  1977-12
View more
  3 in total

Review 1.  In vivo models of primary brain tumors: pitfalls and perspectives.

Authors:  Peter C Huszthy; Inderjit Daphu; Simone P Niclou; Daniel Stieber; Janice M Nigro; Per Ø Sakariassen; Hrvoje Miletic; Frits Thorsen; Rolf Bjerkvig
Journal:  Neuro Oncol       Date:  2012-06-07       Impact factor: 12.300

2.  Targeted Doxorubicin Delivery to Brain Tumors via Minicells: Proof of Principle Using Dogs with Spontaneously Occurring Tumors as a Model.

Authors:  Jennifer A MacDiarmid; Veronika Langova; Dale Bailey; Scott T Pattison; Stacey L Pattison; Neil Christensen; Luke R Armstrong; Vatsala N Brahmbhatt; Katarzyna Smolarczyk; Matthew T Harrison; Marylia Costa; Nancy B Mugridge; Ilya Sedliarou; Nicholas A Grimes; Debra L Kiss; Bruce Stillman; Christine L Hann; Gary L Gallia; Robert M Graham; Himanshu Brahmbhatt
Journal:  PLoS One       Date:  2016-04-06       Impact factor: 3.240

Review 3.  Mouse models of glioblastoma for the evaluation of novel therapeutic strategies.

Authors:  Alexander F Haddad; Jacob S Young; Dominic Amara; Mitchel S Berger; David R Raleigh; Manish K Aghi; Nicholas A Butowski
Journal:  Neurooncol Adv       Date:  2021-07-26
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.